The domestic traditional Chinese medicine Class I new drug Ginkgolide B Injection owned by Guangzhou New Huacheng is currently the world's first ginkgo monomer injection and a national major new drug creation project during the 11th Five-Year Plan period. At present, Ginkgolide B has entered the stage of new drug application. If the new drug certificate is obtained, it will become the world's first ginkgo preparation with clearly defined therapeutic components. As the production base of Ginkgolide B Injection, Guangzhou New Huacheng will make significant contributions to the company's future profits and hold important strategic significance.
What does Guangzhou Yudong Health Pharmaceutical Co., Ltd. require? Who is Guangzhou Yudong Health Pharmaceutical Co., Ltd. hiring? recruitment: 经营管理类占比最多占76.9%，其次是销售类占69.2%. What education can get in at ? 本科占比最多占76.9%，其次是大专占23.1%. Work experience required at ? 不限占比最多占38.5%，其次是3-5年占30.8%. Where are the job locations at ? 福州占比最多占30.8%，其次是广州占30.8%. Based on job postings from the past year, for reference only.
Provided by
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
